Cellosaurus logo
expasy logo

Cellosaurus SFT-T2 (CVCL_C6JJ)

[Text][XML][JSON]
Cell line name SFT-T2
Accession CVCL_C6JJ
Resource Identification Initiative To cite this cell line use: SFT-T2 (RRID:CVCL_C6JJ)
Comments Miscellaneous: STR profile from personal communication of Baier, Dina.
Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
Sequence variations
  • Gene fusion; HGNC; HGNC:7627; NAB2 + HGNC; HGNC:11368; STAT6; Name(s)=NAB2-STAT6; Note=NAB2 exon 4 fused to STAT6 exon 2 (PubMed=36428694).
Disease Pleural solitary fibrous tumor (NCIt: C4457)
Solitary fibrous tumour/hemangiopericytoma (ORDO: Orphanet_2126)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 45Y
Category Cancer cell line
STR profile Source(s): Direct_author_submission

Markers:
AmelogeninX
CSF1PO12,13
D3S135815,17
D5S81813
D7S82010,12
D8S117912,13
D13S3178,11
D16S53911,12
D18S5112,15
D21S1128
FGA19,23
Penta D11,13
Penta E10,16
TH019
TPOX8
vWA15,18

Run an STR similarity search on this cell line
Publications

PubMed=36428694; DOI=10.3390/cancers14225602; PMCID=PMC9688590
Bahil Ghanim, Dina Baier, Christine Pirker, Leonhard Mullauer, Katharina Sinn, Gyoergy Lang, Konrad Hoetzenecker, Walter Berger;
Trabectedin is active against two novel, patient-derived solitary fibrous pleural tumor cell lines and synergizes with ponatinib.
Cancers (Basel) 14:5602.1-5602.16(2022)

Cross-references
Encyclopedic resources Wikidata; Q116050500
Entry history
Entry creation15-Dec-2022
Last entry update19-Dec-2024
Version number5